Clinical consequences of polypharmacy in elderly

By Robert L. Maher, J. Hanlon, Emily R Hajjar. Expert Opinion on Drug Safety, 2014

1,808 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Family Practice, Geriatrics and Gerontology

View Paper: https://www.semanticscholar.org/paper/2aadc310d8415299f6b6df8140f12d3aecfdb79f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Lisa M Kalisch-Ellett
2. S. Shakib
3. Nashwa Masnoon
4. G. Caughey

Citations in the corpus

• What is polypharmacy? A systematic review of definitions (2017, background): “risk of adverse effects and harm increases with increasing numbers of medications [9].”